Teva Pharmaceutical Industries Ltd, Taro Pharmaceutical Industries Ltd, Gamida Cell Ltd, UroGen Pharma Ltd, and PolyPid Ltd are the top 5 pharma companies in Israel in 2021 by R&D expenditure. Cumulatively, the top 10 companies in Israel employed a total of 37,118 people in 2021.
Israel-based Teva Pharmaceutical Industries Ltd is one of the leading pharma companies in Israel in 2021 by R&D expenditure. It discovers, develops, manufactures, and commercializes generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, dermatology, cancer, women’s health, and other disease conditions.
The company reported $967 million in R&D expenditures and generated revenue of $15,878 million. The company’s specialty portfolio includes products for respiratory, oncology, central nervous system, and pain therapy areas, and employed 34,713 people.
Protalix BioTherapeutics Inc (Protalix) is another leading pharma company in Israel in 2021 by R&D expenditure. The company develops its proprietary pipeline of recombinant therapeutic proteins through its proprietary technology, ProCellEx plant cell-based protein expression system.
It allows the company to rapidly develop a protein for clinical testing, compared to other protein platforms. Protalix is headquartered in Karmiel, Israel.
Israel-based Taro Pharmaceutical Industries Ltd is one of the leading companies in Israel in 2021 by R&D expenditure. It discovers, develops, and markets healthcare products. The company manufactures prescription drugs, nonprescription drugs, and active pharmaceutical ingredients (APIs).
It develops pharmaceutical products in semi-solid formulations, such as ointments and creams, and other dosage forms including liquids, capsules, and tablets.
The company reported $55 million in R&D expenditures and generated revenue of $549 million, operates through a single business segment, which produces, research, develops, manufactures, and markets pharmaceutical products, and employed 1,455 people.